Cargando…
Centromere protein N may be a novel malignant prognostic biomarker for hepatocellular carcinoma
BACKGROUND: Hepatocellular carcinoma (HCC) is one of the deadliest tumors. The majority of HCC is detected in the late stage, and the clinical results for HCC patients are poor. There is an urgent need to discover early diagnostic biomarkers and potential therapeutic targets for HCC. METHODS: The GS...
Autores principales: | Wang, Qingqing, Yu, Xiaoyan, Zheng, Zhewen, Chen, Fengxia, Yang, Ningning, Zhou, Yunfeng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
PeerJ Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8101454/ https://www.ncbi.nlm.nih.gov/pubmed/33987018 http://dx.doi.org/10.7717/peerj.11342 |
Ejemplares similares
-
LncRNA AC007255.1, an immune-related prognostic enhancer RNA in esophageal cancer
por: Wang, Qingqing, et al.
Publicado: (2021) -
ASPM May be Related to the Malignant Progression of Hepatitis B and is Associated With a Poor Prognosis of Hepatocellular Carcinoma
por: Tan, Siyou, et al.
Publicado: (2022) -
CDKN2A is a prognostic biomarker and correlated with immune infiltrates in hepatocellular carcinoma
por: Luo, Jun-peng, et al.
Publicado: (2021) -
EXOSC10 is a novel hepatocellular carcinoma prognostic biomarker: a comprehensive bioinformatics analysis and experiment verification
por: Meng, Zhi-Yong, et al.
Publicado: (2023) -
Identification of prognostic biomarkers and correlations with immune infiltrates among cGAS-STING in hepatocellular carcinoma
por: Qi, Zhenhua, et al.
Publicado: (2020)